マイネルビジョン菅原明良騎手

Everything Out Of Context

コロナワクチン打つか迷う…😑
副反応がなければそんなに迷わないんだけど。

Sarcoma Southern California For Sarcoma Awareness!

MAKE SURE TO CHEKC OUT THE SKEPPY X TECHNO MERCH COLLAB!! ALL PROCEEDS GO TO THE SARCOMA FOUNDATION 💕

technoblade.com

#GBM is one of the most aggressive, deadly and treatment-resistant cancers that form in the brain. $CNSP #GBM #GlioblastomaMultiforme #Oncology

Delighted for the opportunity to present our #Sarcoma data at #ASCO23 . Grateful for all the help that I receive @ richardbambury Caitriona Goggin Deirdre O’Mahony Seamus O’Reilly Jim Clover Sinéad A. Noonan Cancer Research @UCC

We have decided to stop treatments. The sarcoma has has gotten to aggressive.

Thanks for all the love, prayers and kindness over this 9 year with war. I could not have made it without an amazing team from @moffittcancercenter my family and all of you.

sarcoma has taken my…

Up next is #SARCtrials active #clincialtrials of SARC032, SARC037, SARC038 and SARC041 #sarcoma

It was a great morning to share Good News and raise awareness for sarcoma!

Great talk and noteworthy results presented by dr Elena Palassini today at #ASCO2023 #sarcoma oral abstract session.
Concurrent #chemoradiation in high-risk STS is feasible and effective

Italian Sarcoma Group GEIS Istituto Tumori

#ASCO2023 day 4 #rarecancers

I LOVE YOU GEORGE
This George, and not the disrespectful little shit from the DSMP who taught he was being funny at a charity event for sarcoma.

So proud of Kristine Lacuna, MD for being awarded an #ASCO23 Young Investigator Award, receiving a Conquer Cancer Merit Award, and presenting posters for not one but TWO clinical trials sponsored by NCI CTEP. What a rockstar 🤩 #sarcoma

#sarcoma is heterogeneous clinically and in ctDNA molecular analysis #ASCO23

What a great discussion by Dr. Nam Bui Nam Bui combo chemo+immunotx in #sarcoma . Time for histology specific and randomized trials. With a word of caution in over-interpreting subset analyses in small trials. #ASCO2023 CancerDotNet Vanderbilt Hem / Onc

Let's kick off this @ASCO2023 with the super-interesting presentation of Sandro Pasquali from Istituto Tumori about #histopatologicalresponse after #neoadjuvantchemotherapy in #highriskSTS

#myfirstasco #sarcoma #ASCO2023

Patient Resource | 2023 National Comprehensive Cancer Network (NCCN) Guidelines for Patients: Endometrial Cancer and Uterine Sarcoma
nccn.org/patients/guide…

#gyncsm #UterineCancer

2022.05.08
#東京競馬場
6R 4歳以上1勝クラス
フェイマスダンディ

7R 4歳以上1勝クラス
バニシングポイント

8R 4歳以上2勝クラス
アルメイダミノル

9R 湘南ステークス（3勝クラス）
ジャスティンカフェ

We are advancing a growing pipeline of product candidates for the treatment of highly resistant cancers and viruses.

bit.ly/3N2TvYS
$MBRX #STSLungMets #Sarcoma #AcuteMyeloidLeukemia #Oncology

#ジャスティンカフェ
撮りたいと画が撮れました😄
13ヶ月ぶりの勝利でした
前勝った時の鞍上はノリさん
去年のエプソムCもノリさんで挑みましたね
重賞で善戦しながらもあと一歩届かない中
繋がれたバトンを和生騎手がゴールを決めました
秋の大舞台での走りにも期待です

Love this. Still looks like a medical illustration of Cookie Monster acting out an MoA video

Alagille syndrome (ALGS) is a complex condition with symptoms that can vary greatly from one person to the next. If you’re feeling overwhelmed with what comes next after a diagnosis, here are the first four steps we recommend. themighty.com/topic/rare-dis…

And proud of the MFT Sarcoma team mft who secured best poster BOOS well done 👏

💋my dear💋
#昆明

Drug development is cool ! Check out this video --> The most exciting part of our Cancer Discovery paper is the FGFR1 vs FGFR2 video in the supplemental section AACR
In this schematic movie, apo FGFR1 (left panel) demonstrates rapid P-loop dynamics, while apo FGFR2 (right panel)…